Journal
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
Volume 23, Issue 3, Pages 1647-1656Publisher
WILEY
DOI: 10.1111/jcmm.13976
Keywords
amyotrophic lateral sclerosis; apoptosis; microRNAs; motor neurons; necroptosis; therapy
Categories
Funding
- EU Community JPND DAMNDPATHS
- Agenzia di Ricerca per la Sclerosi Laterale Amiotrofica smallRNALS
- regione lombardia TRANS-ALS
- Ministero della Salute [RF-2013023555764]
Ask authors/readers for more resources
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder affecting upper and lower motor neurons (MNs), resulting in paralysis and precocious death from respiratory failure. Although the causes of ALS are incompletely understood, the role of alterations in RNA metabolism seems central. MicroRNAs (miRNAs) are noncoding RNAs implicated in the regulation of gene expression of many relevant physiological processes, including cell death. The recent model of programmed cell death (PCD) encompasses different mechanisms, from apoptosis to regulated necrosis (RN), in particular necroptosis. Both apoptosis and necroptosis play a significant role in the progressive death of MNs in ALS. In this review, we present key research related to miRNAs that modulate apoptosis and RN pathways in ALS. We also discuss whether these miRNAs represent potential targets for therapeutic development in patients.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available